Tabula Rasa HealthCare (TRHC) Misses Q3 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Tabula Rasa Healthcare (TRHC) PT Lowered to $22 at Cantor Fitzgerald
November 5, 2021 11:59 AM EDTCantor Fitzgerald analyst Steven Halper lowered the price target on Tabula Rasa Healthcare (NASDAQ: TRHC) to $22.00 (from $40.00) while maintaining a Neutral rating.
The analyst commented, "We reiterate our Neutral rating on TRHC shares and lower our price target to $22 from $40. After the market... More
